Skip to content

Clinical and Economic Evaluation of Acupuncture for Migraine

Clinical and Economic Evaluation of Acupuncture for Migraine : A Multi-Center Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170612002
Enrollment
240
Registered
2017-06-12
Start date
2017-06-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Efficacy of acupuncture for migraine Adverse events from acupuncture treatment Cost of acupuncture treatment Migraine Acupuncture Economics

Interventions

Investigators in each site give acupuncture treatment to participants twice a week for total of 5 sessions. The methods of acupuncture treatment and acupoints used are the same in every participants.,
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Sponsors

Department for Development of Thai Traditional and Alternative Medicine, Ministry of Public Health
Lead Sponsor
Faculty of Medicine Chulalongkorn University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Participants had history of headache for at least 1 year, and had frequency of headache at least 2 times per month. 2. Participants have fulfilled the criteria of migraine disease according to the International Classification of Headache (ICH 2013), both migraine with aura, migraine without aura and chronic migraine. 3. Participants can read Thai language and sign inform consent.

Exclusion criteria

Exclusion criteria: 1. Having been treated with acupuncture for headache during the last 3 months 2. Pregnancy 3. Presentation of severe underlying disease 4. Bleeding tendency 5. Skin infection in the acupoints area 6. Psychosis i.e. schizophrenia

Design outcomes

Primary

MeasureTime frame
Average per subject reduction in migraine days/4 weeks Baseline and 4 weeks after treatment Headache diary (days)

Secondary

MeasureTime frame
Headache intensity Baseline, at visit 5th, visit 10th and 4 weeks after treatment Average of the Numeric Pain Rating Scale each migraine attack, scale of 0-10, from headache diary,Acute Migraine Medication Use Baseline, at visit 5th, visit 10th and 4 weeks after treatment Total amount and type of medication use from headache diary,Quality of Life Baseline, at visit 5th, visit 10th and 4 weeks after treatment EQ-5D-5L questionnaire,Migraine Disability Assessment Baseline and three months after the last treatment The MIDAS (Migraine Disability Assessment) questionnaire ,Proportion of responders Comparing baseline and 4 weeks after treatment of the two groups Proportion of participants who have at least 50% reduction in migraine days of the two groups.,Related Adverse Events from acupuncture Every treatment session Details of adverse events from headache diary and interviewing

Contacts

Public ContactThanan Supasiri

King Chulalongkorn Memorial Hospital

thanans@hotmail.com66813455595

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026